YFQLXB-UC-01

N/A

Report date: 2025/03/04 11:21:59

Base Information

Drug NameYFQLXB-UC-01
Drug Alias NameYFQLXB-UC01YFQLXB-UC-01
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsPresbyopiaRespiratory Distress Syndrome, AdultLiver Cirrhosis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShandong Qilu Cell Treapy Engineering&Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShandong Qilu Cell Treapy Engineering&Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsPresbyopiaRespiratory Distress Syndrome, AdultLiver Cirrhosis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A